Used as a key intermediate in the synthesis of non-steroidal anti-inflammatory drugs (NSAIDs), particularly in the production of bromfenac, which is employed to treat ocular inflammation and pain following cataract surgery. Its structure allows for selective inhibition of cyclooxygenase (COX) enzymes, contributing to reduced prostaglandin synthesis and anti-inflammatory effects. Also utilized in research settings for developing new analgesic and anti-inflammatory compounds due to its reactive functional groups that enable further chemical modifications.